Cargando…
Assessment for the identification of better HDAC inhibitor class through binding energy calculations and descriptor analysis
Histone Deacetylase (HDAC) inhibitors represent a budding class of targeted anti-cancer agents. This structurally diverse group of molecules can induce growth arrest, differentiation, apoptosis, and autophagocytic cell death of cancer cells. Of the different classes of HDAC the class I and Class II...
Autores principales: | Subha, Kalyanamoorthy, Kumar, Gopal Ramesh |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Biomedical Informatics Publishing Group
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2646192/ https://www.ncbi.nlm.nih.gov/pubmed/19255637 |
Ejemplares similares
-
Identification of a better Homo sapiens Class II HDAC inhibitor through binding energy calculations and descriptor analysis
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2010) -
Selection of an improved HDAC8 inhibitor through structure-based drug design
por: Vijayakumar, Balakrishnan, et al.
Publicado: (2011) -
Molecular dynamics simulation of complex Histones Deacetylase (HDAC) Class II Homo Sapiens with suberoylanilide hydroxamic acid (SAHA) and its derivatives as inhibitors of cervical cancer
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2013) -
Distinguishing compounds with anticancer activity by ANN using inductive QSAR descriptors
por: Jaiswal, Kunal, et al.
Publicado: (2008) -
Development of a less toxic dichloroacetate analogue by docking and descriptor analysis
por: Subramanian, Kannan, et al.
Publicado: (2010)